Michael Bös

3.5k citations

43 papers · 1.8k indexed · h-index 21

Cellular and Molecular Neuroscience top 2%
- Neurotransmitter Receptor Influence on Behavior 10
- Neuroscience and Neuropharmacology Research 5
- Neuropeptides and Animal Physiology 5
Hepatology top 5%
- Hepatitis C virus research 10
Biological Psychiatry top 10%
Organic Chemistry top 5%
Molecular Biology top 10%
- Receptor Mechanisms and Signaling 13
- Chemical Synthesis and Analysis 5
Infectious Diseases
- HIV/AIDS drug development and treatment 8
Epidemiology
- Hepatitis B Virus Studies 6

Co-authors: Andrew J. Sleight Claus Riemer Anne Bourson Frank Boess James R. Martin F. Jenck Bernard Levet‐Trafit Jean‐Luc Moreau
Cited by: Cellular and Molecular Neuroscience Hepatology Biological Psychiatry
Journals: Journal of Medicinal Chemistry (8 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)Helvetica Chimica Acta (3 papers)
Partner nations: Switzerland Canada Austria

In The Last Decade

Michael Bös

42 papers receiving 1.7k citations

Peers

Countries citing papers authored by Michael Bös

Since Specialization

Citations

This map shows the geographic impact of Michael Bös's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Bös with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Bös more than expected).

Fields of papers citing papers by Michael Bös

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Bös. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Bös. The network helps show where Michael Bös may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael Bös, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Bös Line = papers co-authored together Michael Bös links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A potassium channel agonist protects hearing function and promotes outer hair cell survival in a mouse model for age-related hearing loss Cell Death and Disease ·García Br,Marcus Müller,Michael Bös,庆来冯,Michael Burnet,Mara Tornincasa,Riccardo Rizzetto,Jean‐François Rolland,VV Tewari,Stefan Lohmer,Youssef Adel,Hubert Löwenheim	2022	11
2	Discovery of a novel series of non-nucleoside thumb pocket 2 HCV NS5B polymerase inhibitors Bioorganic & Medicinal Chemistry Letters ·Timothy A. Stammers,René Coulombe,Jean Rancourt,Bounkham Thavonekham,Gulrez Fazal,Sylvie Goulet,Araz Jakalian,Gordon Storholm,Youla S. Tsantrizos,Marc‐André Poupart,Michael Bös,Ginette McKercher,Louise Thauvette,George Kukolj,Pierre L. Beaulieu	2013	19
3	2 Blunting the Swiss Army Knife of Hepatitis C Virus: Inhibitors of NS3/4A Protease Progress in medicinal chemistry ·Peter W. White,Montse Llinàs‐Brunet,Michael Bös	2006	9
4	Design and synthesis of a novel, achiral class of highly potent and selective, orally active neurokinin-1 receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Torsten Hoffmann,Michael Bös,Heinz Stadler,Patrick Schnider,Walter Hunkeler,Thierry Godel,Guido Galley,Theresa M. Ballard,Guy A. Higgins,Sonia Poli,Andrew J. Sleight	2005	34
5	Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency Bioorganic & Medicinal Chemistry Letters ·Pierre L. Beaulieu,Michael Bös,Yves Bousquet,Patrick DeRoy,Gulrez Fazal,Jean Gauthier,James Gillard,Sylvie Goulet,Ginette McKercher,Marc‐André Poupart,Arina Nur. Ngaini,George Kukolj	2004	74
6	Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives Bioorganic & Medicinal Chemistry Letters ·Pierre L. Beaulieu,Michael Bös,Yves Bousquet,Gulrez Fazal,Jean Gauthier,James Gillard,Sylvie Goulet,Steven R. LaPlante,Marc‐André Poupart,Sylvain Lefèbvre,Ginette McKercher,Charles Pellerin,Volkhard Austel,George Kukolj	2003	82
7	Novel nevirapine-like inhibitors with improved activity against NNRTI-resistant HIV: 8-heteroarylthiomethyldipyridodiazepinone derivatives Bioorganic & Medicinal Chemistry Letters ·Christiane Yoakim,Pierre Bonneau,Robert Déziel,Louise Doyon,Jianmin Duan,Ingrid Guse,Serge Landry,Éric Malenfant,Julie Naud,William W. Ogilvie,Disney Press,Raymond Plante,Bruno Simoneau,Bounkham Thavonekham,Michael Bös,Michael G. Cordingley	2003	22
8	5-HT6 receptor antagonists: lead optimisation and biological evaluation of N-aryl and N-heteroaryl 4-amino-benzene sulfonamides European Journal of Medicinal Chemistry ·Michael Bös,Andrew J. Sleight,Thierry Godel,James R. Martin,Claus Riemer,Heinz Stadler	2001	40
9	Characterization of Ro 04‐6790 and Ro 63‐0563: potent and selective antagonists at human and rat 5‐HT₆ receptors British Journal of Pharmacology ·Andrew J. Sleight,Frank Boess,Michael Bös,Bernard Levet‐Trafit,Claus Riemer,Anne Bourson	1998	150
10	The Putative 5‐ht₆ Receptor: Localization and Function Annals of the New York Academy of Sciences ·Andrew J. Sleight,Frank Boess,Michael Bös,Anne Bourson	1998	34
11	The 5-Hydroxytryptamine6 Receptor-Selective radioligand [3H]Ro 63–0563 Labels 5-Hydroxytryptamine Receptor Binding Sites in Rat and Porcine Striatum Molecular Pharmacology ·Frank Boess,Claus Riemer,Michael Bös,Tamara K. Shirokova,Anne Bourson,Andrew J. Sleight	1998	62
12	Suppression of mutagenic activity of a series of 5HT^2C receptor agonists by the incorporation of a gem-dimethyl group: SAR using the Ames test and a DNA unwinding assay Mutagenesis ·Silvio Albertini,Michael Bös,Elmar Gocke,Stephan Kirchner,Wolfgang Muster,Jürgen Wichmann	1998	10
13	Involvement of 5‐HT₆ receptors in nigro‐striatal function in rodents British Journal of Pharmacology ·Anne Bourson,Frank Boess,Michael Bös,Andrew J. Sleight	1998	71
14	O-Methylasparvenone, a nitrogen-free serotonin antagonist Bioorganic & Medicinal Chemistry ·Michael Bös,Nasirov Otabek Nazirzhanovich,سليمان ، هالة أحمد,Atsuko Nakano,Torero Maximo,Andrew J. Sleight	1997	22
15	Resolution, EPC‐Syntheses, Absolute Stereochemistry, and Pharmacology of the (S)‐(+)‐ and (R)‐(—)‐Isomers of the MAO‐A Inhibitor Tetrindole Hydrochloride Archiv der Pharmazie ·Michael Bös,Nasirov Otabek Nazirzhanovich,R. Kettler,H. H. Keller,Peter Schönholzer	1995	2
16	Optionsbewertung und Kapitalmarkt Michael Bös	1991	1
17	Characterization of the binding of [3H]Ro 41-1049 to the active site of human monoamine oxidase-A. Molecular Pharmacology ·Andrea M. Cesura,Michael Bös,M. D. Galva,R. Imhof,M. Da Prada	1990	28
18	Synthesis of rel‐(3RS,3aSR,7aSR)‐3‐(4‐Chlorophenyl)‐3a,4,5,6,7,7a‐hexahydro‐1‐methylindolin‐6‐one, the Main Metabolite of the Analgesic Ro 15‐8081: A Potent Amine‐Uptake Inhibitor Helvetica Chimica Acta ·Michael Bös,Willy P. Burkard,Jean‐Luc Moreau,Peter Schönholzer	1990	3
19	Sydnone und Sydnonimine Chemie und Pharmakologie Pharmazie in unserer Zeit ·Michael Bös,Wilhelm Fleischhacker	1984	6
20	Lichtinduzierte Reaktionen an Morphinderivaten, 1. Etherbrückenphotolyse an 7,14‐Cyclodihydrocodeinon Liebigs Annalen der Chemie ·Michael Bös,Wilhelm Fleischhacker	1981	1

About Michael Bös

Michael Bös is a scholar working on Hepatology, Cellular and Molecular Neuroscience and Organic Chemistry, having authored 43 papers that have together received 1.8k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (13 papers), Neurotransmitter Receptor Influence on Behavior (10 papers), Hepatitis C virus research (10 papers), HIV/AIDS drug development and treatment (8 papers), Hepatitis B Virus Studies (6 papers), Chemical Synthesis and Analysis (5 papers), Neuroscience and Neuropharmacology Research (5 papers) and Neuropeptides and Animal Physiology (5 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (858 citations), Hepatology (201 citations) and Biological Psychiatry (48 citations). Michael Bös has collaborated with scholars based in Switzerland, Canada and Austria. Frequent co-authors include Andrew J. Sleight, Claus Riemer, Anne Bourson, Frank Boess, James R. Martin, F. Jenck, Bernard Levet‐Trafit, Jean‐Luc Moreau, J. Wichmann and Joel R. Martin. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Helvetica Chimica Acta, European Journal of Medicinal Chemistry and Molecular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact